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A B S T R A C T
GP5 and M, the major membrane proteins of porcine reproductive and respiratory syndrome virus (PRRSV), are
the driving force for virus budding and a target for antibodies. We studied co-translational processing of GP5
from an European PRRSV-1 strain. Using mass spectrometry, we show that in virus particles of a Lelystad
variant, the signal peptide of GP5 was absent due to cleavage between glycine-34 and asparagine-35. This
cleavage site removes an epitope for a neutralizing monoclonal antibody, but leaves intact another epitope
recognized by neutralizing pig sera. Upon ectopic expression of this GP5 in cells, signal peptide cleavage was
however ineﬃcient. Complete cleavage occurred when cysteine-24 was changed to proline or an unused gly-
cosylation site involving asparagine-35 was mutated. Insertion of proline at position 24 also caused carbohydrate
attachment to asparagine-35. Glycosylation sites introduced downstream of residue 35 were used, but did not
inhibit signal peptide processing. Co-expression of the M protein rescued this processing defect in GP5, sug-
gesting a novel function of M towards GP5. We speculate that a complex interplay of the co-translational
modiﬁcations of GP5 aﬀect the N-terminal structure of the mature proteins and hence its antigenicity.
1. Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV, a
plus-strand RNA virus categorized in the order Nidovirales, family
Arteriviridae) is currently the most relevant viral pathogen in pigs
worldwide, with signiﬁcant economic impact. PRRSV infection causes
abortion and stillbirth in pregnant sows as well as respiratory disease
and poor growth performance in piglets (An et al., 2011; Chand et al.,
2012). PRRSV was previously divided into two distinct genotypes
termed “European” and “North American”, but because of the low
nucleotide identity (approx. 50%) they are now classiﬁed as two spe-
cies, PRRSV-1 and PRRSV-2, respectively (Kuhn et al., 2016). The early
isolates Lelystad virus (LV, type 1, (Meulenberg et al., 1993; Wensvoort
et al., 1991)) and VR-2332 (type 2, (Collins et al., 1992)) serve as re-
spective prototype strains. Since their discovery, both genotypes have
spread worldwide. PRRSV has diversiﬁed rapidly by mutation and re-
combination, including the occurrence of highly pathogenic variants in
China ((Tian et al., 2007), related to type 2) and Eastern Europe
((Karniychuk et al., 2010), related to type 1).
The glycoprotein 5 (GP5) is the major envelope protein of PRRSV. It
comprises an N-terminal signal peptide followed by a short ectodomain
of roughly 30 residues, a hydrophobic transmembrane region and an
endodomain. GP5 forms a disulphide-linked complex involving cysteine
50 (Veit et al., 2014) with the non-glycosylated M protein. This GP5/M
complex is relevant for virus assembly/budding as well as binding of
virions to cellular attachment factors (Van Breedam et al., 2010;
Wissink et al., 2005; Zhang and Yoo, 2015). For equine arteritis virus
(EAV), the prototype arterivirus, it was shown that heterodimerization
of M with GP5 is required for their transport from the endoplasmic
reticulum (ER) to the Golgi apparatus, the viral budding site (de Vries
et al., 1995). M might also aﬀect the reactivity of antibodies against
GP5: An escape mutant of PRRSV was described that had become re-
sistant to a broadly neutralizing antibody owing to a deletion of one
amino acid in the ectodomain of M, with likely implications on the
interaction with GP5 (Trible et al., 2015). This is in line with former
studies showing that GP5/M heterodimerization is critical for the ex-
pression of the neutralization epitopes of arteriviruses (for review see
(Balasuriya and MacLachlan, 2004; Dea et al., 2000; Lopez and Osorio,
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2004)).
GP5 is targeted to the rough endoplasmic reticulum (ER) by the
signal peptide and then translocated into the ER lumen through the
“translocon”, a hetero-oligomeric complex serving as channel in the ER
membrane. During translocation, a number of co-translational mod-
iﬁcations are performed on the nascent protein, most importantly N-
glycosylation on asparagine residues in the sequence context N-X-S/T
(“sequon”), cleavage of the signal peptide, and oligomerisation. The
enzyme complexes for N-glycosylation (oligosaccharyl transferase,
OST) and signal peptide cleavage (signal peptidase, SPase) are asso-
ciated with the translocon (but not necessarily in the same complex) to
perform their activity once a nascent polypeptide chain becomes ac-
cessible (Dudek et al., 2015; Shrimal et al., 2015).
Signal peptides, typically ∼30 residues in length, consists of an N-
region containing positively charged residues, a hydrophobic H-region
and a small C-region with the cleavage site (Auclair et al., 2012). The N-
terminus of a nascent protein is inserted as a hairpin into the trans-
locon. The N-region of the signal peptide is oriented to the cytosolic
site, the H-region forms an α-helix that is bound to a hydrophobic
groove located outside the translocon, and the C-region is located en-
tirely inside the channel. Thus, at some point during translocation the
signal peptide must adopt a more extended conformation such that the
cleavage site becomes accessible to the signal peptidase (Li et al., 2016;
Voorhees and Hegde, 2016).
Signal peptides are often, but not always cleaved by signal pepti-
dase, the catalytic subunit of which is a serine-like protease. Whether
and where a signal peptide is cleaved depends primarily on the pre-
sence of small and neutral amino acids (Ala, Gly, Ser, Thr, Cys) at the
−1 and −3 position with respect to the cleavage site (Von Heijne,
1983). Some more distant features that can inﬂuence signal peptide
cleavage have been identiﬁed: In prokaryotic signal peptides the
boundary between the H-region and the C-region is marked by a helix-
breaking residue (mostly Pro at the−6 position), which is required for
eﬃcient cleavage (Auclair et al., 2012; Shen et al., 1991). Conversely, a
proline residue at the +1 position (but not any other amino acid)
prevents cleavage of the signal peptide; such a construct was also
shown to be an eﬀective inhibitor of signal peptidase (Cui et al., 2015).
Another feature that may inﬂuence signal peptide cleavage is the con-
current attachment of a carbohydrate chain through N-glycosylation at
sites near the signal peptide cleavage site. A bulky glycan can obstruct
signal peptide cleavage, as we showed for the glycoprotein of another
Arterivirus, GP3 of equine arteritis virus (EAV), where glycosylation at
a unique overlapping sequon adjacent to the signal peptide completely
blocked signal peptide cleavage. Deletion of both sites causes complete
cleavage and virus particles containing GP3 without a signal peptide
did not show a replication-defect in cell culture (Matczuk et al., 2013;
Matczuk and Veit, 2014).
Thus, the glycoproteins of arteriviruses appear to follow unusual, in
part unpredictable co-translational processing schemes. This processing
warrants close investigation, not least because antibody epitopes were
hypothesised to lie within the C-region of the signal peptide, particu-
larly in case of GP5 of PRRSV (Ostrowski et al., 2002; Plagemann,
2004a,b; Plagemann et al., 2002; Popescu et al., 2017). Thus, signal
peptide cleavage may aﬀect the presence of such epitopes in the mature
protein. For GP5 of various PRRSV-2 strains, we previously determined
that signal peptide cleavage occurs eﬃciently in transfected cells. Mass
spectrometry of GP5 present in virus particles of the VR 2332 strain
revealed that cleavage occurs at either of two sites, leading to retention
or removal, respectively, of an antibody epitope situated between these
two sites (Thaa et al., 2013). Deep sequencing of RNA isolated from pigs
that showed virus rebound after experimental infection revealed var-
ious nonsynonymous nucleotide exchanges, especially in ORF5. The
region involved correspond to the N-terminal region of GP5, the ex-
changed amino acids are located around the signal peptide cleavage
site, but also within the signal peptide. The most exchanges were
identiﬁed at day 28 after infection, shortly before virus reappeared in
the blood and thus may be the result of virus escape from neutralizing
antibodies (Chen et al., 2016; Evans et al., 2017).
For type 1 PRRSV signal peptide processing of GP5 could also have
implications regarding the presence of a neutralizing antibody epitope.
Monoclonal GP5-directed antibodies from mouse raised against the
strain Intervet 10 (I10) neutralised infectivity of a plaque-puriﬁed
subpopulation of this strain (PPV), but failed to neutralise the closely
related Lelystad virus (Weiland et al., 1999). Sequencing revealed four
amino acid diﬀerences between PPV-GP5 and LV-GP5, but only the
cysteine-to-proline exchange at position 24 (located within the signal
peptide) aﬀected antibody reactivity. Surprisingly though, position 24
is not part of the antibody epitope, which was identiﬁed by Pepscan
analysis to encompass residues 29–35 (WSFADGN) of GP5, thus si-
tuated around the potential signal peptide cleavage sites. It was hy-
pothesised–but never assessed experimentally—that cysteine at posi-
tion 24 of GP5 may cause signal peptide cleavage at a site downstream
of the antibody epitope, resulting in mature GP5 lacking the epitope
(Wissink et al., 2003). Sera from PRRSV-infected pigs did not recognize
the WSFADGN epitope of the monoclonal antibody questioning its
physiological relevance. The pig sera rather bind to a not precisely
deﬁned epitope (encompassing residues 38–54) located in the middle of
the ectodomain of GP5 (Plagemann, 2004a,b).
The purpose of this study was to explore the molecular requirements
for co-translational processing of GP5 of PRRSV-1 and to identify the
exact signal peptide cleavage site to provide a better understanding of
the primary structure of the N-terminal region of the mature GP5
protein. Thousands of diﬀerent GP5 nucleotide sequences present in the
database show the enormous variability of PRRSV and its evolution
(Murtaugh et al., 2010) and nucleotide exchanges occurring in GP5
during PRRSV infection in pigs have been reported (Chen et al., 2016;
Evans et al., 2017; Faaberg et al., 2006; Vu et al., 2011; Wei et al.,
2012a). However, studies which investigate GP5 on the protein level
are rather rare, but relevant to identify the amino acids (and their
modiﬁcations) actually to be found in the mature protein and thus
exposed to the immune system.
2. Materials and methods
2.1. Cells, viruses, plasmids and protein processing analysis
Cell culture of CHO-K1 (Chinese hamster ovary cells) and MARC-
145 (simian kidney epithelial cells derived from MA-104) cells were
maintained as described (Thaa et al., 2013). The isolate of Lelystad
virus (LV) was described previously (Costers, 2008; Costers et al.,
2010). The GP5 gene of LV, reverse-transcribed from LV-RNA and
cloned into pExpr-IBA3 (IBA Life Sciences) (Costers, 2008; Costers
et al., 2010), was used as template for PCR to subclone the GP5 gene
into the expression vector pCMV-TnT (Promega) using the XhoI and
NotI restriction sites. The sequence encoding a C-terminal HA tag was
included in the reverse primer; the start codon of the overlapping
ORF5a protein (Firth et al., 2011; Johnson et al., 2011) was disrupted
by an A-to-G mutation in the forward primer, a silent mutation re-
garding the GP5-encoding sequence. Site-directed mutagenesis was
performed by overlap-extension PCR (Green and Sambrook, 2012). The
M–YFP vector was generated by subcloning the LV-M gene (GenBank
M96262), obtained by gene synthesis (Euroﬁns), into pEYFP-N1 using
XhoI and KpnI. Accuracy of the constructs was veriﬁed by sequencing.
Signal peptide cleavage was essentially assessed as described before
(Thaa et al., 2013). Brieﬂy, transfected cells in 6-well plates were
trypsinsed at 24 h after transfection, pelleted and resuspended in 80 μL
glycoprotein denaturing buﬀer (0.5% SDS, 40 mM DTT) and boiled for
10 min at 100 °C. Typically, 15 μL of this lysate was digested with
PNGase F or Endo H (New England BioLabs, 2.5–5 units/μL, 4 h at
37 °C) according to the manufacturer’s instructions, with control sam-
ples left untreated. Samples were then subjected to SDS-PAGE and
Western blot following standard procedures (Thaa et al., 2013), using
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rabbit-anti-HA tag (ab9110, Abcam, Cambridge, UK, 1:5000) and a
horseradish peroxidase-coupled anti-rabbit secondary antibodies
(Sigma).
In vitro transcription/translation was performed with the TNT Quick
Coupled Transcription/Translation System (Promega) as described
(Thaa et al., 2013). For immunoprecipitation, cells were lysed with
RIPA buﬀer (20 mM Tris·HCl, 150 mM NaCl, 10 mM EDTA, 10 mM io-
doacetamide, 0.1% (w/v) SDS, 1% (v/v) Triton X-100, 1% (w/v) so-
dium deoxycholate, pH 7.4), followed by incubation with rabbit-anti-
GFP antibody (Molecular Probes, A11122) at 4 °C for 16 h with agita-
tion, addition of protein A–sepharose (Sigma), further incubation for
2 h at 4 °C, pelleting and washing with RIPA and elution with SDS-
PAGE loading buﬀer prior to SDS-PAGE and Western blot.
2.2. Mass spectrometry
Viruses were pelleted from supernatants of infected MARC-145 cells
as described (Thaa et al., 2013). Proteins were reduced with 10 mM
DTT (in 50 mM ammonium bicarbonate buﬀer for 45 min at 56 °C),
alkylated with iodoacetamide (55 mM) and deglycosylated with
PNGase F for 4 h at 37 °C prior to SDS-PAGE and Coomassie staining.
GP5 was identiﬁed by Western blot with the monoclonal anti-GP5 an-
tibody 3AH9 (Rodriguez et al., 2001) using an aliquot run on an ad-
jacent lane. GP5 was excised from the gel followed by either in-gel
chymotrypsin (in 50 mM ammonium bicarbonate buﬀer for 20 h at
25 °C) or elastase (in 50 mM ammonium bicarbonate at 37 °C over-
night) digest, peptide extraction with triﬂuoroacetic acid (TFA) in
acetonitrile, drying and reconstitution in 0.1% TFA/5% acetonitrile.
NanoLC-ESI–MS/MS was performed on an Orbitrap Elite hybrid mass
spectrometer (Thermo Scientiﬁc) equipped with an Ultimate 3000 NCS-
3500RS liquid chromatography system (Thermo Scientiﬁc). MS data
were acquired in a data-dependent strategy selecting MS/MS frag-
mentation events based on the precursor abundance in the MS scan. MS
and MS/MS spectra were used to search against a custom-made data-
base containing all proteins of the SwissProt database, including the
full-length LV-GP5 sequence (Costers, 2008). In addition, the database
contained all possible N-terminally truncated sequences of GP5 re-
sulting from signal peptide cleavage site prediction. Asn/Asp amino
acid exchanges were used as variable modiﬁcations. For identiﬁcation
of GP5 peptides, the processed MS/MS spectra were compared with the
theoretical fragment ions of GP5 peptides using the MASCOT server
version 2.2.2 (Matrix Science), allowing a maximum of six mixed
chymotrypsin cleavages, with a mass tolerance of precursor and se-
quence ions set to 10 ppm and 0.35 Da, respectively.
2.3. Bioinformatics resources
Signal peptide cleavage site predictions were performed with
SignalP 4.1 (Petersen et al., 2011), (http://www.cbs.dtu.dk/services/
SignalP/). Sequence alignments were done using EMBOSS (http://
www.ebi.ac.uk/Tools/psa/emboss_needle/). Graphical representations
of multiple sequence alignment were generated with WebLogo (Crooks
et al., 2004), (http://weblogo.berkeley.edu/logo.cgi).
3. Results
3.1. Bioinformatic predictions of the N-terminal ectodomain of GP5
Fig. 1A shows the sequence of the N-terminal region of GP5 em-
ployed in this study, cloned from a laboratory variant of the PRRSV-1
prototype strain Lelystad (Costers, 2008; Costers et al., 2010). Of note,
GP5 in our variant of Lelystad virus carries an amino acid substitution
at position 37 (aspartic acid to serine, (Costers, 2008)) as compared to
the sequence of the original Lelystad isolate (Meulenberg et al., 1993).
Importantly, this creates a glycosylation sequon (N-X-S/T) at position
35 adjacent to one of the predicted signal peptide cleavage sites;
35NGD37 in the original LV isolate is mutated to 35NGS37. The two
other glycosylation sites at positions 46 and 53 are present in both
variants of the Lelystad virus and conserved in all PRRSV-1 strains. See
supplementary Table 1 for the complete GP5 sequences. The region
from amino acid tyrosine 41 to cysteine 50 in the conserved ectodomain
forms a β-sheet structure according to secondary structure predictions
with Jpred; the preceding region (34–40) is unfolded and more vari-
able. Residue 50 is the only cysteine in the ectodomain and forms the
disulphide bond to the M protein (Veit et al., 2014). The N-terminal
region comprises the features of a canonical signal peptide (positively
charged N-region, hydrophobic H-region predicted to form an α-helix,
C-region, see Fig. 1A). Adjacent to the signal peptide is a hypervariable
region (see also Fig. 3A) containing mainly the amino acids N, S and T.
It was shown that GP5 can rapidly acquire or loose potential glycosy-
lation sites in this region during virus evolution in pigs (Chang et al.,
2002; Kwon et al., 2008).
Several positions between residues 27 and 35 fulﬁl the requirements
for a signal peptide cleavage site (small/uncharged residues at positions
−3 and −1). We employed the SignalP algorithm (Petersen et al.,
2011) to predict cleavage eﬃciency (Fig. 1B). According to this ana-
lysis, the most probable cleavage site is located between A32 and D33,
which is within the monoclonal antibody epitope 29WSFADGN35.
Other potential sites (albeit predicted with lower probability) are lo-
cated with a regular spacing of two amino acids upstream and down-
stream of A32 (26G27L, 28S29W, 30S31F, 34G35N, 36G37S). Cleavage
at the most N- or C-terminal sites would either leave the antibody
epitope entirely unaﬀected or would completely remove it, respec-
tively.
3.2. Signal peptide cleavage of GP5 in transfected cells
To analyse signal peptide cleavage we did not utilize the classical
approach using in vitro translation in the presence of microsomes
(Blobel and Dobberstein, 1975) since (due to ineﬃcient translocation
and glycosylation) it usually produces multiple GP5 bands that com-
plicate interpretation of the data (Thaa et al., 2013). Instead, we ex-
pressed GP5 in cells and compared the SDS-PAGE mobility of the de-
glycosylated protein with the product synthesized in vitro, which
remains unglycosylated, but retains the signal peptide. We generated an
expression plasmid comprising GP5, cloned from the laboratory variant
of Lelystad having the glycosylation sequon at position 35, fused at the
C-terminus with an HA tag for subsequent antibody detection. We also
mutated cysteine 24 in the signal peptide to proline (GP5 C24P). This
exchange corresponds to the sequence found in the Intervet 10 virus
strain which was neutralised by a monoclonal antibody that failed to
neutralise Lelystad virus (Weiland et al., 1999; Wissink et al., 2003). We
hypothesised that the identity of residue 24 might inﬂuence signal
peptide cleavage to aﬀect the presence of the epitope in mature GP5.
To biochemically assess signal peptide cleavage, MARC-145 cells,
which are permissive for PRRSV, were mock-transfected or transfected
with either GP5 wt or GP5 C24P, cell lysates were prepared 24 h post-
transfection, digested with the enzyme peptide:N-glycosidase F
(PNGase F) to remove all N-linked glycans and subsequently analysed
by SDS-PAGE and Western blot (Fig. 2A). For comparison, GP5 wt was
also generated from the same plasmid by in vitro transcription/trans-
lation in the absence of membranes. The product of this reaction is
neither processed by signal peptide cleavage nor N-glycosylated and
thus represents a “size marker” for unprocessed GP5 wt, running at an
apparent molecular weight of ∼18 kDa (lane 1). Western blot of
PNGase treated samples revealed two bands for GP5 wt (lane 6), the
upper of these bands corresponding in size to the unprocessed GP5 “size
marker” (lane 1) and thus representing deglycosylated GP5 with signal
peptide, while the lower band ran faster and thus corresponds to the
deglycosylated protein lacking the signal peptide. Since the two bands
were of roughly the same intensity, the signal peptide of GP5 wt was
cleaved with low eﬃciency. In contrast, the deglycosylated GP5 C24P
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mutant displayed almost exclusively the lower band, representing
protein without signal peptide (lane 7). We conclude that the removal
of a cysteine or the insertion of proline at position 24 positively aﬀected
signal peptide processing.
In the glycosylated samples (without PNGase F digestion), GP5 wt
displayed two major bands (lane 3), whereas the C24P variant (lane 4)
only showed one band, migrating similarly than the upper GP5 wt band.
Considering that GP5 C24P lacks the signal peptide and that both the
signal peptide and one carbohydrate chain typically contribute around
2.5 kDa to the apparent molecular weight of a glycoprotein, it can be
concluded that GP5 C24P carried one additional glycan compared to
GP5 wt–i.e., two glycans in the wt version, but three glycans in the
C24P mutant of GP5.
N-glycosylation at position 35 might inhibit signal peptide cleavage
by steric hindrance as described for GP3 of EAV (Matczuk et al., 2013).
Therefore, we changed the sequon N35-G36-S37 to NGD (GP5 NGD).
This GP5 now corresponds to the sequence of GP5 of the original Le-
lystad strain (GenBank M96262.2). After performing the processing
analysis, the deglycosylated proteins showed that the signal peptide
was (almost) completely cleaved in GP5 NGD, irrespective of whether
residue 24 was cysteine or proline (Fig. 2B). The glycosylated versions
of the two proteins did not markedly diﬀer in size, which indicates that
the two conserved glycosylation sites were used in each case. In sum, a
glycosylation site at position 35 plus a cysteine at position 24 within the
signal peptide prevented complete signal peptide processing in GP5.
3.3. Glycosylation sites and signal peptide cleavage
We next asked whether the N-glycosylation sequon at position 35 is
used and also whether N-glycosylation sequons introduced at down-
stream positions in the vicinity (36, 37 or 38) would have a similar
eﬀect on signal peptide cleavage. Such glycosylation sites can easily be
gained by a single amino acid mutation in the hypervariable region. In
fact, the majority of “European” PRRSV-1 GP5 sequences comprise an
N37-S38-S39 sequon, revealed by sequence alignment of 988 PRRSV-1
GP5 sequences deposited at ncbi.nlm.nih.gov (Fig. 3A).
We expressed a panel of GP5 mutants where either no asparagine
was present in this region (GP5 N35S) or where N was in a sequon
context at either position 35, 36, 37 or 38. Residue 24 was cysteine as in
GP5 wt. These mutants did not markedly diﬀer from each other in
bioinformatic prediction analysis using SignalP (not shown).
Biochemical processing analysis was performed for these mutants
(Fig. 3B). After PNGase F digestion, a double-band pattern was detected
for the N35 variant, as observed before (Fig. 2A). All the other variants
of GP5 displayed only one major band corresponding in the size to the
lower band of the N35 variant, indicating that the signal peptide was
completely cleaved. Small diﬀerences in electrophoretic mobility sug-
gest that the position of signal peptide cleavage might be shifted. Based
on the migration pattern without PNGase F treatment (Fig. 3B, top
panel), we conclude that the additional glycosylation sites in the N36,
N37 and N38 variants of GP5 were used. The N35 sequon however was
not used: The upper band of the glycosylated N35 variant displayed a
higher molecular weight as the N35S mutant owing to the signal pep-
tide.
Thus, partial prevention of signal peptide processing in GP5 re-
quired the unused sequon NGS at position 35. Hence, the obstruction of
signal peptide cleavage was not due to a glycan at N35, but due to some
other feature. To analyse whether the glycine at position 36, a residue
known to disrupt α-helical structures, aﬀects signal peptide processing
we changed it to alanine (GP5 G36A). Furthermore, we also in-
vestigated the contribution of position 24 within the signal peptide. To
determine whether the presence of cysteine 24 is relevant for obstruc-
tion of signal peptide cleavage, for example by forming an in-
tramolecular disulphide bond, we exchanged it to a serine (GP5 C24S).
Either of these mutations was introduced into GP5 with a glycosylation
sequon at position 35 and analysed with the processing assay (Fig. 3C).
The result shows that neither of these mutations had an eﬀect on signal
peptide cleavage and glycosylation, both GP5 C24S and GP5 G36A
displayed a partially uncleaved signal peptide and two carbohydrates
like the corresponding wildtype. We conclude that the glycine at po-
sition 36 had no eﬀect on signal peptide cleavage and that it is the
insertion of a proline (and not the removal of the cysteine) at position
24 that allowed complete signal peptide cleavage.
3.4. Identiﬁcation of signal peptide cleavage site of GP5 by mass
spectrometry
Next, we analysed signal peptide cleavage site of GP5 present in
virus particles. The Lelystad variant having the glycosylation sequon at
position 35 was pelleted from the supernatant of infected MARC-145
cells. When the virus particles were analysed by Western blot with a
GP5 antibody (Fig. 4A), a band at an apparent molecular mass of
∼22 kDa was detected. Upon PNGase F treatment, only one band with
a molecular mass of ∼14 kDa was observed, suggesting that virions
Fig. 1. Predicted signal peptide cleavage of PRRSV-
GP5.
(A) Amino acid sequence of the N-terminal part
(signal peptide plus ectodomain) of the GP5 em-
ployed in this study. Relevant features are high-
lighted: Potential N-glycosylation sequons in bold
(black lozenges indicates conserved sites, the white
lozenge marks the non-conserved glycosylation site),
cysteine 50 (forms the disulphide bond to M) in bold,
residue 24 bold and underlined, possible signal
peptide cleavage sites derived from the prediction in
(B) indicated by triangles. The epitope WSFADGN
recognized by a monoclonal antibody (Wissink et al.,
2003) and the epitope recognized by pig sera en-
compassing residues 38–54 (Plagemann, 2004a;
Plagemann, 2004b) are underlined with a continuous
and dotted line, respectively. Secondary structure
prediction (Jpred) in the bottom line (H: α-helix, E:
β-sheet).
(B) SignalP 4.1 signal peptide cleavage prediction for
GP5. The “Y value” as a measure of signal peptide
cleavage probability at the indicated residue is dis-
played; threshold (0.5) indicated by the dotted line.
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contain only GP5 with cleaved signal peptide.
To identify the cleavage site deglycosylated GP5 was excised from
the gel and in-gel digested with chymotrypsin or elastase. The resulting
peptides were subjected to mass spectrometry (LC-ESI–MS/MS). In two
independent virus preparations, GP5 was identiﬁed with 65–80% se-
quence coverage (percentage referring to GP5 with signal peptide). We
failed to detect any peptides comprising residues located N-terminally
to residue 35. A peptide starting with N35 was detected in both elastase
and chymotrypsin-digested samples (…adg|NGSSSTYQYIY|nlt…, dis-
played in Fig. 4B). Thus, N35 is likely to be the N-terminus of mature
GP5 in virus particles since it does not match a canonical chymotrypsin
cleavage site (Keil, 1992). Conversely, the cleavage site…ADG|N…
corresponds to the amino acid pattern recognized by signal peptidase.
Thus, the signal peptide of GP5 in the virus was eﬃciently cleaved at
G34|N35, one of the highly likely sites predicted by SignalP (see
Fig. 1B), albeit not the site with the highest cleavage probability
(A32|S33). This result also implies that the GP5 molecules incorporated
into virus particles lacked the neutralizing epitope (residues 29–35),
consistent with the result that this virus was not neutralised by
monoclonal antibodies directed against this epitope (Wissink et al.,
2003). However, the epitope recognized by pig sera (encompassing
residues 38–54) is present in the mature GP5 protein from virus par-
ticles.
An identical cleavage site was identiﬁed in GP5 of an Intervet 10
strain (Fig. 4C), which contains the sequence N35-G36-D37 and
therefore no glycosylation sequon at N35. We identiﬁed two peptides
starting with N35 (sequence N35GDSSTYQYI and
N35GDSSTYQYIYNLT), but no peptides with residues N-terminal to N35
in GP5 of our virus sample upon elastase digest. Sequencing of the
ORF5 mRNA from this Intervet 10 strain revealed that the signal pep-
tide of GP5 contains a cysteine at position 24 (data not shown) and not
the proline that is required for neutralization of the plaque-puriﬁed
variant of Intervet 10 by the monoclonal antibody (Wissink et al.,
2003).
3.5. Signal peptide cleavage of GP5 in cells co-expressing M
One obvious diﬀerence between virus infection and our transfection
approach is that the dimerisation partner for GP5, the M protein, was
not present in the latter. To address whether the processing defects of
GP5 may be rescued by co-expression of M, we co-transfected cells with
the plasmid encoding GP5–HA wildtype together with M, fused at the C-
terminal cytoplasmic tail to the yellow-ﬂuorescent protein (YFP).
Control samples were transfected with M–YFP alone, GP5–HA on its
own or GP5–HA plus native (unfused) YFP. Western blot (anti-HA tag,
Fig. 5A) showed the prominent double-band pattern of GP5–HA when
expressed on its own or together with YFP, indicating incomplete signal
peptide cleavage. Upon co-expression of M–YFP however, the pattern of
GP5–HA instead comprised a lower sharp band, at the same position as
the band of glycosylated GP5–HA without signal peptide, plus a blurry
signal at higher apparent molecular weight.
Blurry signals containing several bands are due to heterogeneous
glycosylation of GP5 with complex carbohydrates by Golgi-located
glycosyltransferases (Li et al., 2015). Indeed, the upper signal in
GP5–HA co-expressed with M–YFP was retained upon treatment with
endoglycosidase H (Endo H, Fig. 5B). This enzyme removes high-
mannose N-linked glycans, but not the modiﬁed glycans present on
glycoproteins after passage through the medial-Golgi. Thus, a fraction
of GP5 molecules was transported to the medial-Golgi (or further) when
co-expressed with M, consistent with a previous demonstration for GP5
of EAV using immunoﬂuorescence microscopy (de Vries et al., 1995).
To substantiate an interaction between GP5 and M, we performed
immunoprecipitation under denaturing, but non-reducing conditions
using an anti-GFP antibody to pull down M–YFP and analysed samples
by Western blot with anti-HA antibodies to visualise co-precipitated
GP5–HA (Fig. 5C). GP5–HA signals were exclusively detected for the
condition where M–YFP and GP5–HA were co-expressed.
Finally, we analysed whether co-expression with M facilitates signal
peptide processing of GP5. The band pattern of PNGase F-digested
samples (Fig. 5D, upper part) clearly shows that co-expression of
GP5–HA with M–YFP led to complete cleavage of the signal peptide.
However, when cysteine 50 in GP5–HA was exchanged by serine (C50S)
to prevent disulphide-bond formation with M (Veit et al., 2014), signal
peptide cleavage of GP5 remained ineﬃcient also upon co-expression
with M. Blotting of the same samples with an anti-GFP antibody showed
that the expression levels of M-YFP are very similar regardless of
whether GP5-HA wt or GP5-HA C50S were co-expressed (Fig. 5D, lower
part).
4. Discussion
The signal peptide of GP5 present in virus particles of a variant of
the Lelystad strain, the prototype strain of “European” PRRSV-1, was
completely cleaved between glycine 34 and asparagine 35 as de-
termined by mass spectrometry (Fig. 4). This also removed the epitope
WSFADGN (residues 29–35, determined by Pepscan analysis) for a
Fig. 2. Processing analysis of GP5 in transfected cells.
(A) MARC-145 cells were mock-transfected (Ø) or transfected with the indicated HA-
tagged GP5 constructs (residues 21–40 are displayed). GP5-HA wt has an identical amino
acid sequence as GP5 from a variant of PRRSV Lelystad with a glycosylation sequon at
position N35. Cells were lysed at 24 h post-transfection, subjected to PNGase F digestion
to remove N-linked glycans (lanes 5–7) or left untreated (lanes 2–4) and analysed by SDS-
PAGE/Western blot (anti-HA tag). The product of in vitro transcription/translation of
GP5-HA wt (= unprocessed protein, not glycosylated, containing the signal peptide) is
shown in lane 1. Arrows indicate the position of deglycosylated proteins with (black) and
without (white) signal peptide (SP), respectively. Note that there are also minor GP5
bands visible in the samples without PNGase F digestion. They probably represent un-
glycosylated GP5 with (upper band) and without (lower band) signal peptide.
(B) Processing analysis as in (A) with the indicated versions of GP5-HA-constructs. The
GP5-HA (NGD) has an identical amino acid sequence as the GP5 from the original PRRSV
isolate Lelystad (Meulenberg et al., 1993), diﬀering from the GP5 wt in Fig. 2A by aspartic
acid instead of serine at position 37. All images are representative of three independent
experiments. Molecular weight markers displayed on the left-hand side.
B. Thaa et al. Virus Research 240 (2017) 112–120
116
monoclonal antibody which did not neutralise the Lelystad strain of
PRRSV, conﬁrming the assumption that the epitope is absent in mature
GP5 present in virus particles (Weiland et al., 1999; Wissink et al.,
2003). However, the epitope recognized by pig sera (encompassing
residues 38–54) is present in the mature GP5 protein of PRRSV-1
(Plagemann, 2004a,b).
The signal peptide of GP5 of “European” PRRSV-1 is thus larger (34
amino acids) compared to GP5 of “North American” PRRSV-2, where
two cleavage sites (after residues 26 and 31, respectively) were de-
termined using the same methodology (Thaa et al., 2013). However,
there is likely more variability in the location of the cleavage site(s) in
diﬀerent PRRSV strains. GP5 contains a cluster of putative cleavage
sites (small amino acids with a regular spacing of two amino acids) in
the C-region of the signal peptide (Fig. 1) which might alternatively be
used if a mutation occurs at the initially preferred cleavage site. In
addition, attachment of carbohydrates to asparagine 36, 37 and 38
(note that asn 37 is a glycosylation sequon in most PRRSV-1 strains,
Fig. 3A) also seemed to inﬂuence the position of signal peptide cleavage
since the corresponding GP5 mutants have slightly diﬀerent SDS-PAGE
mobility after deglycosylation (Fig. 3B).
Upon expression of wildtype GP5 of the same virus strain by
transfection, in the absence of the M protein, we however observed that
a large fraction of the protein still contained the signal peptide (Fig. 2).
A systematic biochemical analysis revealed a variety of diﬀerent fea-
tures that inhibited eﬃcient signal peptide cleavage: Incomplete clea-
vage of the signal peptide was observed in the context of the sequences
NGS or NAS at the N-terminus of the mature protein (Fig. 2A and 3C),
while amino acids not encoding a glycosylation sequon (NGD (Fig. 2B),
SGS, NND and SGN (Fig. 3) allowed complete cleavage. However, the
glycosylation sequon NGS was not used and thus sterical hindrance of
the cleavage site by a bulky carbohydrate was not the reason for in-
complete processing. Furthermore, insertion of additional glycosylation
sites at position 36, 37 or 38 led to modiﬁcation of the respective sites
with a glycan and seemed to inﬂuence the position of signal peptide
cleavage but did not inhibit signal peptide processing itself (Fig. 3B).
The inhibitory eﬀect of the glycosylation sequon was rescued by
insertion of a proline at position 24 within the signal peptide (−11
relative to the cleavage site, Fig. 2A). This is reminiscent of bacterial
Fig. 3. In-depth analysis of sequence features and glycosylation sites inﬂuencing signal peptide cleavage in GP5.
(A) Multiple sequence alignments of 988 GP5 sequences of PRRSV type 1 (extracted from ncbi.nlm.nih.gov, ﬁrst 70 residues), displayed as sequence logo. The size of the amino acids
corresponds to their frequency with the “bits” being a measure of sequence conservation (the higher, the more conserved; (Crooks et al., 2004)). The black lozenge indicates the conserved
N-glycosylation sites, the white lozenge the non-conserved glycosylation site in proximity to the signal peptide (cf. Fig. 1A). Note that GP5 proteins from most PRRSV-1 strains have a
glycosylation sequon at position 37 and a cysteine at position 24.
(B) Processing analysis of mutants of GP5-HA with additional glycosylation sites at the indicated positions. N35 (wt) is the GP5 from the variant of the Lelystad virus having a
glycosylation site at position 35 already analysed in Fig. 2A. Amino acid exchanges relative to this GP5 are in bold and italics. Potential glycosylation sites are underlined. Used
glycosylation sites are marked with an asterisk.
(C) Processing analysis of GP5-HA with mutations at residue 24 or in the glycosylation sequon N35-G36-S37 as indicated. Wt is the GP5 from the variant of the Lelystad virus having a
glycosylation site at position 35 already analysed in Fig. 2A. Amino acid exchanges relative to this GP5 are in bold and italics. Potential glycosylation sites are underlined. Used
glycosylation sites are marked with an asterisk. GP5 was expressed in CHO-K1 cells. See legend to Fig. 2 for details.
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signal peptides where a proline at position −6 is required for eﬃcient
cleavage. We assume, as suggested for prokaryotic signal peptides
(Shen et al., 1991) that the proline enables the α-helical H-region of the
signal peptide to adopt a more extended conformation. Since the crystal
structure of the translocon containing a nascent polypeptide chain re-
vealed that the signal peptide cleavage site is located entirely inside the
channel (Li et al., 2016) the ability to adopt a more extended con-
formation might be a prerequisite to expose it to the lumenal signal
peptidase.
For GP5 proteins of several PRRSV-2 strains we did not observe such
ineﬃcient signal peptide cleavage in transfected cells, although they
contain a (fairly conserved) cysteine at position 24 and a (only partly
used) glycosylation site downstream of the signal peptide cleavage site
(Thaa et al., 2013). However, GP5 of PRRSV-2 strains contain a con-
served proline at position 22 that might facilitate eﬃcient signal pep-
tide cleavage if the assumed mechanism to enable cleavage is correct.
Nevertheless, considering the large amino acid variability between
PRRSV strains and the unknown mechanism for ineﬃcient signal pep-
tide cleavage we do not want to exclude that GP5 of certain PRRSV-2
strains are also incompletely processed inside cells.
The insertion of proline at position 24 also caused complete glyco-
sylation at residue N35 (Fig. 2), all other GP5 variants having a gly-
cosylation sequon at N35 were never glycosylated at this site. Thus,
features within the signal peptide (and thus at a distance of nine amino
acids from a putative glycosylation site) determine by an unknown
mechanism whether the sequon N35 is used. Attachment of glycans is
supposed to aﬀect the antigenicity of Gp5 by glycan shielding (Faaberg
et al., 2006; Vu et al., 2011; Wei et al., 2012b). Glycan shielding of
epitopes might occur not only by mutations within the hypervariable
region that create additional glycosylation sites (Chang et al., 2002;
Kwon et al., 2008), but also by mutations within the signal peptide that
cause attachment of carbohydrates to an already existent sequon. This
might be relevant since PRRS viruses that escaped antibody neu-
tralization in pigs acquired several amino acid exchanges in the middle
of the signal peptide; a putative carbohydrate attachment site was al-
ready present (Chen et al., 2016).
The most relevant data for signal peptide cleavage is our observa-
tion that co-expression of GP5 with its dimerisation partner, the M
protein, rescued signal peptide cleavage defects of GP5 (Fig. 5). Com-
plete cleavage of the signal peptide required the formation of a dis-
ulphide bond between cysteine 50 in GP5 with cysteine 9 in M, which is
the only cysteine in the small ectodomain of M (9 residues). To our
knowledge, this is the ﬁrst demonstration that a protein of a hetero-
oligomeric complex facilitates signal peptide cleavage of its binding
partner. Mechanistically, binding to M might pull the signal peptide
cleavage site of GP5 out of the translocon such that it becomes acces-
sible to the signal peptidase.
From the perspective of the virus, the interaction of GP5 with M
may be a “rescue mechanism” to allow complete processing of sub-
optimal variants of GP5. Most (∼95%) PRRSV-1 strains have the
“suboptimal” cysteine at position 24 in GP5 (Fig. 3A). An exchange
with a more suitable amino acid, for example a proline, might not be
possible because of sequence requirements for the essential ORF5a
protein (Firth et al., 2011; Johnson et al., 2011; Robinson et al., 2013),
which is translated from an alternative reading frame that overlaps with
the GP5-encoding gene. In addition, the hypervariable region can ra-
pidly acquire potential glycosylation sites during virus evolution
(Chang et al., 2002; Kwon et al., 2008). GP5/M dimer formation could
help certain GP5 variants to cleave their signal peptide and thus ensures
that only properly processed GP5/M complexes (where the signal
peptide of GP5 is cleaved) are incorporated into virus particles. Our
observation adds another facet to the pivotal role of GP5/M hetero-
dimerization for the biology of PRRSV and Arteriviridae in general. It
does not only facilitate transport of these proteins from the ER to the
Fig. 4. Signal peptide cleavage site identiﬁcation in GP5 by mass spectrometry.
(A) Western blot analysis with anti-GP5 antibodies of PRRSV particles (variant of the Lelystad virus having a glycosylation site at position 35) grown in MARC-145 cells, treated with
PNGase F (right panel) or left untreated. Two independent virus preparations are shown.
(B) Result of nanoLC-ESI–MS/MS analysis of deglycosylated LV-GP5. The N-terminal protein sequence with chymotrypsin cleavage sites is shown. Thick bars indicate cleavage after
aromatic and thin bars cleavage after leucine residues. Identiﬁed peptides are displayed as black horizontal bars. The N-terminal end of the ﬁrst peptide (35–45) does not correspond to a
chymotryptic product and hence derives from signal peptide cleavage at G34|N35. The epitope WSFADGN recognized by a monoclonal antibody (Wissink et al., 2003) and the epitope
encompassing residues 38–54 recognized by pig sera (Plagemann, 2004a; Plagemann, 2004b) are underlined with a continuous and dotted line, respectively.
(C) Result of nanoLC-ESI–MS/MS analysis of deglycosylated Intervet 10 GP5. Peptides identiﬁed after elastase digestion, an enzyme without pronounced substrate speciﬁcity, are
displayed as black horizontal bars. The sequence of the ectodomain of this GP5 is identical to LV-GP5 except an exchange of serine 37 to aspartic acid (marked in bold), which disrupts the
potential glycosylation site at residues 35. Alignment of all identiﬁed peptides with the sequence of the plaque-puriﬁed variant (PPV) of I10 revealed that from the four amino acid
diﬀerences between GP5 of PPV and LV, the two residues in the transmembrane region (positions 97 and 103) of PPV were present in our sample. However, one of the identiﬁed peptides
did not match the sequence of PPV (Wissink et al., 2003); position 158 in the cytoplasmic tail was not arginine, but lysine as in LV-GP5. Note also that the signal peptide contains a
cysteine at position 24 (and not the critical proline (Wissink et al., 2003)) as revealed by sequencing of the mRNA of ORF5.
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viral budding site (de Vries et al., 1995), but is also required for virus
budding and viral infectivity (Faaberg et al., 1995; Wieringa et al.,
2004; Wissink et al., 2005) and for the formation of (conformation
dependent) neutralizing antibody epitopes (Balasuriya and
MacLachlan, 2004; Dea et al., 2000; Lopez and Osorio, 2004).
In conclusion, we report that GP5 present in PRRSV-1 virions is
cleaved between glycine-34 and asparagine-35. In transfected cells
signal peptide cleavage is ineﬃcient if GP5 contains an unused glyco-
sylation site at Asn35 located at the N-terminus of the mature protein
plus a cysteine residue at position 24 within the signal peptide.
Exchange of either Cys24 with proline or mutation of the glycosylation
sequon allowed complete signal peptide cleavage. The processing defect
was rescued by oligomerisation of GP5 with its binding partner, the M
protein (see Fig. 6 for a schematic display). Thus, a complex interplay of
the co-translational modiﬁcations N-glycosylation, signal peptide clea-
vage and oligomerisation with the M-protein determines the amino
acids present at the N-terminus of mature Gp5 and also the usage of N-
glycosylation sites. This unpredictable interplay might aﬀect removal of
antibody epitopes or their shielding by glycans and hence might in-
ﬂuence the antigenicity of GP5.
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